Copertina

How ‘miracle’ weight‐loss semaglutide promises to change medicine but can we afford the expense?

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Ralf Weiskirchen, Amedeo Lonardo
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2025
Soggetti:	British Journal of Pharmacology
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Deep learning‐enhanced 3D imaging unveils semaglutide impact on cardiac fibrosis
di: Sheyla Barrado‐Ballestero, et al.
Pubblicazione: (2025)

Network‐based precision medicine and systems pharmacology
di: Arvind K. Pandey, et al.
Pubblicazione: (2025)

Kynurenic acid as a promising therapeutic agent in renal fibrosis: dual modulation of fibrosis and immune crosstalk
di: Sona Sykorova, et al.
Pubblicazione: (2026)

Explainable AI and debiased networks: The ‘last mile’ for precision medicine delivery
di: Siyi Liu, et al.
Pubblicazione: (2025)

Network medicine and systems pharmacology approaches to predicting adverse drug effects
di: Alessio Funari, et al.
Pubblicazione: (2024)

Exploring the antidepressant potential of Yueju Pill: Insights from traditional Chinese medicine
di: Xinyan Wu, et al.
Pubblicazione: (2026)

Methodological considerations for a deep learning‐based prescription framework for traditional Chinese medicine
di: Mingze Ma, et al.
Pubblicazione: (2026)

Digital diagnostics, biomarkers and therapeutics in an evolving healthcare system: From promise to practice
di: Mees H. P. Stoop, et al.
Pubblicazione: (2026)

A deep neural network model for optimizing traditional Chinese medicine prescriptions with data augmentation
di: Xiaohan Mao, et al.
Pubblicazione: (2025)

Integrative immunomodulation in systemic autoimmune diseases: Mechanistic complementarity and therapeutic strategies of traditional Chinese and conventional medicine
di: Xiaomeng Zhang, et al.
Pubblicazione: (2026)

Precision medicine in paediatrics: Progress and priorities
di: Nicola Husain, et al.
Pubblicazione: (2026)

Clinical pharmacology in adolescent transgender medicine
di: Lauren R. Cirrincione, et al.
Pubblicazione: (2024)

Section 19A in practice: Assessing the provision of overseas‐registered medicines to mitigate the impact of medicine shortages in Australia
di: Jack Janetzki, et al.
Pubblicazione: (2025)

The clinical toxicity of advanced therapy medicinal products
di: Fraser J. H. Henderson, et al.
Pubblicazione: (2025)

Developing an international concept‐based curriculum for pharmacology education: The promise of core concepts and concept inventories
di: Clare Guilding, et al.
Pubblicazione: (2024)

Innovations in pharmacovigilance studies of medicines in older people
di: Lisa M. Kalisch Ellett, et al.
Pubblicazione: (2024)

Early erythroferrone levels can predict the long‐term haemoglobin responses to erythropoiesis‐stimulating agents
di: Peng Xu, et al.
Pubblicazione: (2024)

Correction to “Evaluating the impact of general practice pharmacist‐led person‐centred medicines reviews on medicines appropriateness and patient‐reported outcome measures”
Pubblicazione: (2026)

Understanding the influence of transfusion and blood loss on tranexamic acid concentration in scoliosis surgery with blood loss
di: Paula Alexandra Sá, et al.
Pubblicazione: (2025)

Inositol hexaphosphate alleviates ototoxicity and age‐related hearing loss by preserving cochlear hair cells in mice
di: Stella Chin‐Shaw Tsai, et al.
Pubblicazione: (2025)

Morbimortality consequences of use and misuse of psychoactive medicines in Portugal
di: Ana Carmona Araújo, et al.
Pubblicazione: (2025)

Assessment of clinical pharmacology and competence during medicine clerkships
di: Nicole C. Cheung, et al.
Pubblicazione: (2025)

A comprehensive review of anti‐colorectal cancer alkaloids from traditional Chinese medicine: Sources, chemical structures, mechanisms and therapeutic applications
di: Kaiping Cong, et al.
Pubblicazione: (2026)

Anti‐amyloid antibodies in Europe: Where are we now?
di: Danica Juricic Nahal, et al.
Pubblicazione: (2026)

Increased ATP production and P‐glycoprotein activity underlie the marked changes in blood–brain barrier transport of drugs in a mouse model of amyotrophic lateral sclerosis
di: Yijun Pan, et al.
Pubblicazione: (2025)

Early transtympanic administration of rhBDNF exerts a multifaceted neuroprotective effect against cisplatin‐induced hearing loss
di: Anna Pisani, et al.
Pubblicazione: (2024)

Why classical receptor theory, which ignores allostery, can effectively measure the strength of an allosteric effect as agonist's efficacy
di: H. Ongun Onaran, et al.
Pubblicazione: (2024)

Evidence generation throughout paediatric medicines life cycle: findings from collaborative work between European Medicines Agency (EMA) and EUnetHTA on use of extrapolation
di: Dominik Karres, et al.
Pubblicazione: (2024)

Topical application of a P2X2/P2X3 purine receptor inhibitor suppresses the bitter taste of medicines and other taste qualities
di: Linda J. Flammer, et al.
Pubblicazione: (2024)

Advanced therapy medicinal products (ATMPs) – An analysis of the global regulatory status
di: Allan Cramer, et al.
Pubblicazione: (2026)

MCF classifier: Estimating, standardizing, and stratifying medicine carbon footprints, at scale
di: Haroon Taylor, et al.
Pubblicazione: (2024)

Human hypoxia models in aerospace medicine: Potential applications for human pharmacological research
di: Titiaan E. Post, et al.
Pubblicazione: (2024)

Fixed dosing of alpelisib for children with vascular anomalies: Can we do better?
di: Amandine Remy, et al.
Pubblicazione: (2025)

Ethosuximide: Subunit‐ and Gβγ‐dependent blocker and reporter of allosteric changes in GIRK channels
di: Boris Shalomov, et al.
Pubblicazione: (2025)

Assessing the environmental impact of medicines in Italy using data from the Italian Medicines Agency
di: Valentina Giunchi, et al.
Pubblicazione: (2025)

A review on the role of extrapolation as basis for paediatric marketing authorization applications of medicines in the EU
di: Charlotte W. M. Simons, et al.
Pubblicazione: (2025)

Patient preferences and attitudes regarding the environmental impact of medicines: A discrete choice experiment
di: Milad Sadreghaemy, et al.
Pubblicazione: (2025)

Utilization and expenditure on medicines for the management of osteoporosis in Ireland: A repeated cross‐sectional study
di: Amelia Smith, et al.
Pubblicazione: (2025)

Sustainable medicines development and use: Challenges and opportunities in the sustainable production of active pharmaceutical ingredients
di: Gary M. Noonan, et al.
Pubblicazione: (2024)

Community pharmacists' practices and perspectives on deprescribing high‐risk psychotropic medicines: National survey findings
di: Monica Jung, et al.
Pubblicazione: (2026)